Microbiota and immunoregulation: A focus on regulatory B lymphocytes and transplantation
- PMID: 33559282
- DOI: 10.1111/ajt.16522
Microbiota and immunoregulation: A focus on regulatory B lymphocytes and transplantation
Abstract
The microbiota plays a major role in the regulation of the host immune functions thus establishing a symbiotic relationship that maintains immune homeostasis. Among immune cells, regulatory B cells (Bregs), which can inhibit effector T cell responses, may be involved in the intestinal homeostasis. Recent works suggest that the interaction between the microbiota and Bregs appears to be important to limit autoimmune diseases and help to maintain tolerance in transplantation. Short-chain fatty acids (SCFAs), recognized as major metabolites of the microbiota, seem to be involved in the generation of a pro-tolerogenic environment in the gut, particularly through the regulation of B cell differentiation, limiting mature B cells and promoting the function of Bregs. In this review, we show that this B cells-microbiota interaction may open a path toward new potential therapeutic applications not only for patients with autoimmune diseases but also in transplantation.
Keywords: B cell biology; basic (laboratory) research/science; immune regulation; immunobiology; immunosuppression/immune modulation; microbiomics; organ transplantation in general; translational research/science.
© 2021 The American Society of Transplantation and the American Society of Transplant Surgeons.
References
REFERENCES
-
- Bach J-F. The hygiene hypothesis in autoimmunity: the role of pathogens and commensals. Nat Rev Immunol. 2018;18(2):105-120.
-
- Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nat Rev Immunol. 2016;16(6):341-352.
-
- Mauri C, Menon M. Human regulatory B cells in health and disease: therapeutic potential. J Clin Invest. 2017;127(3):772-779.
-
- Rosser EC, Oleinika K, Tonon S, et al. Regulatory B cells are induced by gut microbiota-driven interleukin-1β and interleukin-6 production. Nat Med. 2014;20(11):1334-1339.
-
- Rosser EC, Piper CJM, Matei DE, et al. Microbiota-derived metabolites suppress arthritis by amplifying aryl-hydrocarbon receptor activation in regulatory B cells. Cell Metab. 2020;31(4):837-851.e10.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources